chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Temperature (tmax 102.9) Superficial dermal reaction to vaccination site (L arm) at injection site and extending slightly proximally and distally.  Severe body aches/pains Nausea without vomiting  Generalized fatigue/malaise
Employee called clinic-did not come to work today. Generalized body aches, joint stiffness-back, legs. States feels feverish-but employee has not taken temp. Mild headache. States sym-began Fri 10/25 over wknd and improving today. Has been taking ASA for sym.
Mother states that baby was fine with no fever after immunizations until midnight 11/2/07.  Had been giving Tylenol q 4 hrs since immunization.  Baby woke up for a bottle and temp was 105 axillary.  Took child to ER.  According to ER record temp was 100.1 rectally on arrival.  Was told to continue Tylenol & follow-up with PMD next day.  Was ok next day.
shingles outbreak; This case was reported by a physician via sales rep and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, unknown after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The physician reported that a female patient developed outbreak of shingles on the arm after first dose of Shingrix.   No further details were available. The reporter consented to follow up.
nausea; vomiting; dehydration; weakness; She is not really able to really eat or drink; This is a spontaneous report from a contactable consumer (patient's daughter) from a Pfizer-sponsored program COVAX US Support. A 62-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: EW0161 and Expire Date: unknown) via an unspecified route of administration in right arm on Saturday 29May2021 (reported as at like 14:00-14:15), as a single dose for covid-19 immunisation at Shopping mall, operated by the state. Medical history included ongoing diabetes, obesity, and heart stent. Concomitant medications included acetylsalicylic acid (BABY ASPIRIN) at a dose of 81mg (lot no: P123777, expiry date: Jan2023, UPC:8113169958) and clopidogrel bisulfate (PLAVIX) 75mg once daily both received while hospital discharge on 05May2021 for heart stent (heart disorder). Patient previously received Penicillin (this was years ago, onset date since she was a child) which made to lose her pigmentation and had allergy. Patient had no previous immunization with the Pfizer vaccine and no additional vaccines administered on same date of the Pfizer Suspect. Patient did not receive any other vaccines within four weeks prior to vaccinations. Family medical history relevant to adverse event was none. On 31May2021 around 12:00, the patient had onset of nausea and vomiting. These both events were persistent, with dehydration and weakness ongoing relative to not being able to keep anything down. She was not really able to really eat or drink. She can't really take her medicine and due to her condition, having a heart stent she has to take blood thinner Plavix and Aspirin. The events were not resulted in emergency room and physician office but has a follow-up doctor's appointment but not related to these adverse events. The outcome of event eating disorder was unknown and for other events was not recovered.  Additional information requested.
This is a 39-year-old active duty Dentist who received his 2nd yellow fever vaccination on 3/8/2004.  He was immunized in preparation for movement which is currently in another area. This is pre-commissioned vessel.  He had his last yellow fever in 1990 and had no previous reaction. He began to experience pain (5/10) intermittently at the injection site in the left triceps area. His pain has gotten progressively worse with radiation to elbow, forearm and 3rd and 4th digits left hand. He also has experienced some radiation to left trapezius and posterior cervical area. His pain remains constant and is described at a dull ache (3-4/10). At times he has sharp stabbing pain (9/10) and other times is 7/10. He has also has noticed some reduced sensation in the 3rd & 4th digits of the left hand. He was referred to the VHC by Dr. for further evaluation and treatment.
Loss of consciousness approximately 9:10pm, fall, multiple head and face lacerations. Entered ER ~11:00pm and received multiple tests, EKG, TDAP injection, and sutures.
This spontaneous report as received from a nurse practitioner refers to a 60 year old female patient. Concurrent condition included Attention deficit/hyperactivity disorder (ADHD), allergic rhinitis, hypothyroidism, hepatitis C and intolerance to TYLENOL with nausea, vomiting and diarrhea. The patient's medical history included glaucoma. On 20-JUN-2014 the patient was vaccinated with a dose of ZOSTAVAX, (lot number not specified) through an unspecified route. Concomitant therapies included FLONASE, SYNTHROID, EXCEDRIN MIGRAINE, ADDERALL Tablets, loratadine (manufacturer unknown), PERCOCET and VENTOLIN Inhaler. On an unknown date in 2014 (2 to 6 weeks after injection) the patient developed creepy crawlies in her left cheek with headaches, this was further described by nurse practitioner as similar to neuralgia in left cheek or prodromal symptoms of Zoster. The nurse practitioner stated that patient never developed rash. The patient told nurse that she had left cheek numbness and sharp stabbing pain in entire left side of head. On an unknown date in November 2014 the patient was treated with oral AUGMENTIN for sinus infection. On an unknown date in December 2014, the patient was diagnosed with pneumonia after chest x-ray and chest computerised axial tomography (CAT) scan. Additional treatment included LEVAQUIN, tapering steroids, NEURONTIN, oxycodone, coconut oil swish, spit and INDOCIN. All treatments were not effective to left cheek event. The patient sought medical attention on 08-JAN-2015 where she had a normal cranial nerve assessment. On 08-JAN-2015 the patient had high sensitivity at left cheek with swelling with streak of pain from left bridge of nose to left ear which was pallor color. The patient's lab studies included CBC, Chem 7 and ESR were with normal range but the folate level was high. The nurse practitioner stated that patient's current diagnosis was a condition known as ice pick headache, idiopathic stabbing headache, or jabbing and jolting headache (disability). The outcome of the events was reported as not recovered. The reporter did not assess the causality for the events. The patient was referred to neurology and MRI of head is scheduled. The event ice pick headache, idiopathic stabbing headache, or jabbing and jolting headache was considered serious due to serious criteria of disability. Additional information has been requested.
First shot I have a rash which my doctor diagnosed as COVID arm. It was itchy and raised, it presented 7 days after my first shot.   Second shot, by 10p I had a fever of 101, chills, body ache, nauseous and headache. The next day I got COVID arm on the left arm again and a different rash presented itself on my right arm. I had a fever for over 24 hours with the other symptoms listed. It?s 4/23, my fever has gone away. The only symptoms I?m still having are the rashes
Dizziness, Fatigue started around 4PM on 9/22/2020.  Patient claims he slept for about an hour from fatigue but when woke up from phone ringing, he did not realized he had slept and he may have passed out because he does not remember going to sleep.  Around 7PM, his temperature was 101F oral.  He claims his temperature has been getting better as of today, Friday 9/25/2020 around 12PM and did not record it but his fatigue is better also.
Progressivley rising temp w/hives culminating in one febrile seizure w/t104 approx 630PM; 25AUG91 meningitis ruled out; Baby respiked temp; 26AUG91 temp to 105.7 w/o sz;
A couple hundred EXTREMELY itchy hive or chicken pox-like lesions on extremities and ears.  At first looked like about 8 mosquito bites, and when I got up in the morning I had them all over.  They were red with small blister-like centers that the next day or so drained a clear light yellow sticky substance.  I have pictures on my cell phone.  After a few days they got a little scab in the middle and stopped itching.  I had about 3 distinct waves of these, as one batch was healing another very itchy round began.  A month later now, the larger one, about 20 are still red with a larger scab in the center, many have faded out, but there is still about 50 that are light brown in color on their way to fading.  I took nor applied anything during this time.
Extreme fatigue.  Random dizzy spells. Multiple bowel movements throughout the day. Runny and solid.  (5 in 6 hours). Body aches and heat flashes.
Began to have pain in hip that progressed to severe pain and parlaying leg and foot; Unable at 2 nd week to stand or walk; Unable at 2 nd week to stand or walk; Began to have pain in hip that progressed to severe pain and parlaying leg and foot; This is a spontaneous report from a contactable consumer (parent). A 27-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on 30Apr2021 at 15:30 (at the age of 27 years) as unknown dose, single for COVID-19 immunization. Medical history included obesity and mental illness. Concomitant medications included aripiprazole (ABLIFY), sertraline hydrochloride (ZOLOFT), metformin, bupropion hydrochloride (WELLBUTRIN), simvastatin and lisinopril. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, it was unknown if the patient was tested for COVID-19. The patient was hospitalized on 27Apr2021 for an unknown reason and began to have pain in hip that progressed to severe pain and parlaying leg and foot on 03May2021. Unable at the second week to stand or walk. These adverse events result in emergency room (ER) or department or urgent care. The patient's hospitalization was prolonged and the patient was disability as a result of these events. It was unknown if the treatment was received by the patient due to these events. It was reported that the duration of hospitalization was 10 days discharged on 07May2021 (also reported as continued, CLARIFICATION PENDING). The outcome of all these events was not recovered at the time of report.  Information on the lot/batch number has been requested.
This spontaneous report as received from a registered nurse refers to an unknown number of patients of unknown age and gender (no demographic details were provided). The medical history of the patients was unknown. On an unknown date, the patients received GARDASIL, intramuscular that was exposed to 31F for four hours. No adverse effects were reported. Additional information has been requested.
Patient initially felt discomfort throughout her body and was unease. At this time, two Diphenhydramine 25mg tablets were given to the patient orally. Then five minutes later, patient had slight syncope. Then three minutes later, patient complained of discomfort in the throat area. Then 2 minutes later patient expressed pain and tightness in the throat area and was disoriented. At this point, one Epinephrine injection of 0.3mg was given intramuscularly in upper outer thigh area and 911 was called. Patient was monitored closely until Emergency Paramedics arrived.
I felt nauseated, lightheaded and had an odd pain in my head which began soon after the vaccinations. I couldn't focus my eyes on anything slightly bright for longer than a few seconds. Later that night my eyesight became blurry and everything looked 'gummy' and saw tracers. Turning my head too much to either side made the head pain worse. The next day I went to work and the lights in the office and my computer were making me nauseated and I nearly vomited on several occasions. I wasn't able to eat anything for lunch. I left work early that afternoon and went to the emergency room. I was prescribed some Motrin and nausea medication and given 24-hour quarters. The next day I slept most of the day, because I felt horrible and it hurt my eyes to watch tv. Everything looked 'swirly' and I had trouble with short-term memory loss. I randomly walked across a busy street and was nearly hit by a car. I was afraid to drive while this was affecting me, things just looked weird. The symptoms slowly decreased over the course of the next 2 weeks. During that time, I felt very disoriented and lightheaded, very tired, and my eyes were not normal.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2 booster doses of Moderna Covid-19 vaccine were given beyond 12 hrs., but less than 24hrs of exposure to room temperature.) and PRODUCT STORAGE ERROR (vial was exposed to room temperature range (8° to 25°C= 46° to 77°F): 23hrs 2 min/initially stored in the refrigerator: 10:38am 04May2022) in an 83-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M21A) for COVID-19 vaccination. No Medical History information was reported. On 05-May-2022 at 9:40 AM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 05-May-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (2 booster doses of Moderna Covid-19 vaccine were given beyond 12 hrs., but less than 24hrs of exposure to room temperature.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was exposed to room temperature range (8° to 25°C= 46° to 77°F): 23hrs 2 min/initially stored in the refrigerator: 10:38am 04May2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (2 booster doses of Moderna Covid-19 vaccine were given beyond 12 hrs., but less than 24hrs of exposure to room temperature.) and PRODUCT STORAGE ERROR (vial was exposed to room temperature range (8° to 25°C= 46° to 77°F): 23hrs 2 min/initially stored in the refrigerator: 10:38am 04May2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine (Unknown), the reporter did not provide any causality assessments. Dose administered >12(US)/24(CA) hours post puncture. The vial was initially stored in the refrigerator at 10:38 am on 04-May-2022. On 04-May-2022, at 10:38 am vial was first punctured. On 05-May-2022, at 09:40 am administration of vaccine. The vial was stored in Room temp, out of direct light post puncture. The vial did not undergo any temperature excursions. Total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F) was reported as 23hrs 2 min. No treatment medication was reported. Most recent FOLLOW-UP information incorporated above includes: On 05-May-2022: Follow up contains no new information.
Information has been received from a nurse concerning a 24 year old Asian female lab assistant embryologist who was vaccinated, as a child, in her native "country", with 3 dose RECOMBIVAX HB series, manufacturer unknown. In 19-JUN-2003, the patient received a RECOMBIVAX HB booster (manufacturer unknown) in the left deltoid. In 2003, the patient underwent an antibody blood test drawn and failed to seroconvert, results were less than 10. Nurse states one booster dose of RECOMBIVAX HB, unknown which hepatitis B, was administered in 2003, and another titer drawn post vaccination showed client still failed to seroconvert. In follow-up, it was reported that the patient Hepatitis B serum antibody test February 2007 was <3.0. The patient sought unspecified medical attention. Additional information has been requested.
Expired Hep B given 1/13/04 outdated 1/11/04.
Myalgia; Fatigue; Headache; Flu-like Symptoms; This case was reported by a consumer via call center representative and described the occurrence of myalgia in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th June 2020, the patient received the 1st dose of Shingrix (injection). On 9th June 2020, less than a day after receiving Shingrix, the patient experienced myalgia, fatigue, headache and influenza-like symptoms. On 11th June 2020, the outcome of the myalgia, fatigue, headache and influenza-like symptoms were recovered/resolved.   It was unknown if the reporter considered the myalgia, fatigue, headache and influenza-like symptoms to be related to Shingrix.  Additional details were as follows: The patient received 1st dose of Shingrix in right arm. After receiving 1st dose of Shingrix, the patient experienced myalgia, fatigue, headache and influenza-like symptoms. The symptoms lasted approximately 36 hours. On 11th June 2020, she had no other symptoms. The patient called to ask if she should get the next injection and to report the first adverse events. I provided the caller with the Medical Disclaimer, encouraging her to speak with her HCP and information in PI in content. The reporter did not consent to follow up.
No AE Event; HCP called to ask about next steps regarding inadvertent administration of an expired dose of PNEUMOVAX 23.  Expired 8/29/2023 and was administered 10/6/2023. Referenced post expiry memo. Request case reference 02486527. Consent to contact is yes. No; This spontaneous report was received from a nurse, concerning a 40-year-old patient of unknown gender.   The patient's medical history, concurrent conditions and concomitant medication were not reported.  On 06-OCT-2023, the patient was vaccinated with an expired dose of  with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 0.5 milliliter, lot #u032086, has been verified to be valid expiration date: 29-AUG-2023)  administered for prophylaxis (strength, and route of administration were not provided). No adverse events reported.
pt devel warmth & redness @ site of inj 2 days p/vax;erythema approx 9x9cm + tender;no fever;
Allergic reaction - tightening in throat; lower arm/nerve pain; tingling 6 days later; This is a spontaneous report from a non-contactable consumer, the patient. A 41-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6207) via an unspecified route of administration in left arm on March2021 as a single dose for COVID-19 immunisation (at the age of 41-years-old). Medical history included IBS from an unspecified date. The patient was allergic to shellfish. Patient took other medications in two weeks which included multivitamins(MANUFACTURER UNKNOWN), mentha x piperita oil (IBGARD), probiotic (FLORASTOR) from an unknown date for an unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other other vaccine within four weeks prior to vaccination. On an unspecified date in Mach2021 the patient experienced allergic reaction- tightening in throat, lower arm/nerve pain and tingling 6 days later. The patient did not receive any treatment for adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Clinical outcome of allergic reaction- tightening in throat, lower arm/nerve pain and tingling was not recovered.  No follow up attempts are needed. No further information is expected.
lump started to hurt with a slight twitch; lump started to hurt with a slight twitch; a lump between her clavicula and her neck on the left side; This spontaneous case was reported by a consumer and describes the occurrence of NECK MASS (a lump between her clavicula and her neck on the left side), PAIN (lump started to hurt with a slight twitch) and MUSCLE TWITCHING (lump started to hurt with a slight twitch) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004d21a) for COVID-19 vaccination.     Medical history information was not reported.  Concomitant products included MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 24-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Aug-2021, the patient experienced NECK MASS (a lump between her clavicula and her neck on the left side). On 02-Aug-2021, the patient experienced PAIN (lump started to hurt with a slight twitch) and MUSCLE TWITCHING (lump started to hurt with a slight twitch). At the time of the report, NECK MASS (a lump between her clavicula and her neck on the left side), PAIN (lump started to hurt with a slight twitch) and MUSCLE TWITCHING (lump started to hurt with a slight twitch) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
pt recv vax 31JUL96 & p/vax pt exp tightness/distress in chest, temporary numbness & tingling in legs, a funny feeling all over, feeling of tightness, & devel diaphoresis & an in resp rate to 28;BP also inc to 140/88;adm to ER & treated;
p/recv vax pt exp inj site swelling & applied ice; felt feverish & went to bed early; at time of rpt pt inj site swelling persisted;
A Pfizer COVID-19 vaccine that was past the 6-hour expiration time period was administered to patient. Error was realized immediately post-vaccination. Discussed with patient that dose could be subpotent and re-vaccination may be required. Advised patient that I would contact manufacturer regarding necessity/timing of re-vaccination and that she should contact pharmacy with any issues or concerns that come up.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. During 2014, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) at a physician's office, as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. During 2016, the patient was treated at a physician's office for the onset of a persistent and severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expense, and pain and suffering, and other damages. Additional information has been requested.
During drive home from HD, client experienced a numb or tingling feeling in left armpit, Stated that the seatbelt caused discomfort as it pressed against her left arm. By the time she reached home, her arm was sore, limp and she felt flushed, woozy, fatigued. She napped off and on throughout the day, Symptoms diminished the following am but not gone, Client denied, elevated temp., Reported symptoms to physician 24 hours after injection.
Extremely high-blood pressure 15-20 minutes after shot. 177/110.  Rested 45 minutes; bp now at 201/120.  Staff recommends I go to ER.  Nurse drives me to office.  My boss drops me off at hospital ER. EKG done. All stats good. Sent home. Went to GP following day...BP still good...
Swelling & redness in arm Saturday (had sl. bruise Friday after shot) with c/o pain, sl. temp, c/o itch Saturday night. Redness & induration spread Sunday and today. Treatment TYLENOL, ADVIL, ice & BENADRYL x1 Sunday.
Pain in whole shoulder and side of neck. Also swollen, ibuprofen to help w/ pain and inflammation, but it isn't working. It was administered on Monday and it is now Thursday and the pain has worsened. I will be making a ER visit today.